Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism -765 on graft loss after renal transplantation

American Journal of Transplantation

Volumn 9, Issue 12, 2009, Pages 2752-2757

  Courivaud, C ^a,b,c,d   Bamoulid, J ^a,b,c,d   Loupy, A ^e   Deschamps, M ^a,b,c   Ferrand, C ^a,b,c   Le Corre, D ^a,f   Tiberghien, P ^a,b,c,d   Chalopin, J M ^a,b,c,d   Legendre, C ^e   Thervet, E ^e   Saas, P ^a,b,c   Ducloux, D ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d HÔPITAL SAINT JACQUES   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gene polymorphism; Graft failure; Kidney allograft

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; GLYCINE; PROSTAGLANDIN E2;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN BLOOD LEVEL;

ADULT; COHORT STUDIES; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 72449174765     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02830.x     Document Type: Article

References (24)

1. -2004 annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients. Transplant data 1994-2003. Rockville, MD. Health Resources and Services Administration, Division of Transplantation, 2004.
2. Jevnikar AM, Mannon RB. Late kidney allograft loss: What we know about it, and what we can do about it. Clin J Am Soc Nephrol 2008 3 : S56 S67.
3. Bosmans JL, Ysebaert DK, Verpooten GA. Chronic allograft nephropathy: What have we learned from protocol biopsies? Transplantation 2008 85 : S38 S41.
4. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007 7 : 356 365.
5. Tilley SL, Coffman TM, Koller BH. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001 108 : 15 23.
6. Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004 291 : 2221 2228.
7. Fujimoto Y, Iwagaki H, Ozaki M et al. Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model. Int Immunol 2005 5 : 1131 1139.
8. Strom TB, Carpenter CB. Prostaglandin as an effective antirejection therapy in rat renal allograft recipients. Transplantation 1983 35 : 279 281.
9. Kamei TM, Callery P, Flye MW. Intragraft delivery of 16, 16-dimethyl PGE2 induces donor-specific tolerance in rat cardiac allograft recipients. Transplantation 1991 51 : 242 246.
10. Papafili A, Hill MR, Brull DJ et al. Common promoter variant in cyclooxygenase-2 represses gene expression: Evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002 22 : 1631 1636.
11. Blaheta RA, Nelson K, Oppermann E et al. Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. Transplantation 2000 69 : 1977 1981.
12. Freely associating. Nat Genet 1999 22 : 1 3.
13. Nataraj C, Thomas DW, Tilley SL et al. Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J Clin Invest 2001 108 : 1229 1235.
14. Vang T, Abrahamsen H, Myklebust S, Horejsi V, Tasken K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase A inhibits T cell receptor signalling. J Biol Chem 2003 278 : 17597 17600.
15. Van Der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdens J, Arden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J Exp Med 1995 181 : 775.
16. Takahashi HK, Iwagaki H, Yoshino T, Mori S, Morichika T et al. Prostaglandin E2 inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J Immunol 2002 168 : 4446 4454.
17. Straussmann GV, Koota P, Finkelman F, Fong M, Kambayashi T. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by PGE2. J Exp Med 1994 180 : 2365.
18. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002 168 : 2255 2263.
19. Sharma S, Yang S-C, Zhu L et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of Foxp3 expression and CD4+CD25+ T regulatory cell activities in lung cancer. Cancer Res 2005 65 : 5211 5218.
20. Baratelli F, Lin Y, Zhu L et al. Prostaglandin E2 induces FoxP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005 175 : 1483 1490.
21. Yaqub S, Johansson CC, Tasken K, Aandahl EM. FOXP3+ CD4+ CD25+ adaptative regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006 177 : 246 254.
22. Akasaki Y, Liu G, Chung NHC, Ehtesham M, Black KL, Yu JS. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J Immunol 2004 173 : 4352 4359.
23. Okano M, Sugata Y, Fujiwara T et al. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. Immunology 2006 118 : 343 352.
24. Moran M, Mozes MF, Maddux MS et al. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. N Engl J Med 1990 322 : 1183 1188.